Embedded Files
The following patents represent a portfolio of inventions I personally drafted, prosecuted, and successfully defended before the United States Patent and Trademark Office (USPTO), including during reexamination. My work includes composition of matter claims, methods of use, formulations, and unit dosage forms, primarily focused on bioavailable amino acid complexes, nitrate delivery systems, and performance-enhancing supplements.
United States Patents
US 7,777,074 B2: Amino acid nitrates/nitrites (e.g. arginine, citrulline, glutamine) to boost bioavailability, solubility, and vasodilation.
US 8,034,836 B2 – US 8,183,288 B2: Continuations of '074, covering related amino acid compound variations.
US 8,466,187 B2 – US 8,569,369 B2: Further amino acid compositions and dosage/configuration refinements.
US 8,952,045 B1 – US 8,957,101 B1: Unit dosage and formulation innovations of nitrate/amino acid blends.
US 10,646,508 B1: Safe administration methods for nitrate-containing supplements.
US 10,733,916 B1, US 10,736,917 B1: Methods to enhance athletic performance via nitrate supplementation.
US 11,160,298 B2: Methods for decolorizing nitrate rich beetroot-based products
US 11,155,524 B2: Beverage formulation of amino acid nitrate supplement.
US 11,260,096 B2: Creatine supplementation methods optimized for “non-responsive” individuals.
US 11,186,519 B2: N-acetyl beta-alanine usage methods.
US 11,541,020 B2: Hexylamine salt compound and methods.
US 11,568,686 B2: Increased blood oxygen saturation compositions and methods US 11,865,139 B2: Migraines and headache treatment methods.
US 11,633,354 B2: Novel creatine/creatinine compositions.
US 10,470,032 B2, US 10,420,739 B2: Glutaurine compound compositions.
US 9,353,143 B1: Ecdysterone compounds (esters/salts like decanoate or isobutyrate) to enhance bioavailability and muscle distribution.
Published U.S. Applications
US 2025/0019344 A1 – Creatine carbonate compositions
US 2025/0016296–A1 series – Amino acid nitrate formulations
US 2024/0016764 A1 – Hexylamine salts applications
US 2023/0201115 A1, US 2023/0062170 A1 – Creatine/creatinine compositions
US 2023/0057399 A1 – Iron supplement formulations
US 2022/0296638 A1 – Migraine treatment methods
US 2024/0122966–A1 series – Enhanced nitrate compositions
International Patent Applications (PCT)
WO 2020/160509 A1 – Enhanced nitrate composition and methods
WO 2019/055704 A1 – Amino acid nitrate supplement drink
WO 2022/192743 A1 – Methods of increasing blood oxygen saturation
WO 2024/250032 A1 – Soluble curcumin and its derivatives
Canadian Patents
CA 3128232 A1 – Enhanced nitrate compositions
CA 3237722 A1 – Blood oxygen saturation methods
CA 3133696 A1 – Hexylamine salts and methods
European Patents
EP 2696865 B1 – N-acetyl beta alanine methods
EP 3917543 A1 / A4 – Enhanced nitrate composition methods
EP 4433066 A1 – Methods of increasing blood oxygen saturation
Publications:
-Intrinsic Dissolution Profiles of Creatine Nitrate, Creatine Monohydrate and Buffered Creatine
-Chemical Stability of Creatine Nitrate, Creatine Monohydrate and Buffered Creatine in solution
-Equilibrium Solubility of Creatine Nitrate, Creatine Monohydrate and Buffered Creatine in Solution
All above were exhibited at the Pharmaceutical Sciences World Congress of New Orleans 2010 and were published at the AAPS Journal
-Oxygen saturation improved with nitrate-based nutritional formula in patients with COVID-19
https://journals.sagepub.com/doi/10.1177/03000605211012380
-Nitric Oxide: The Missing Factor in COVID-19 Severity?
https://www.mdpi.com/2076-3271/10/1/3
-The Effects of Nitrate-Based Nutritional Formula on Oxygen Saturation and Patient-Reported Outcomes in COVID-19 Patients: A Randomized Controlled Trial
https://www.nchpjournals.com/Manuscript?id=2332&fbclid=IwAR0IggewOEcCpS
DGKFmPGTKCCF2RIgKnMCDDqHjEVjA4ZQv74R6b26nIhjE
Page updated
Google Sites
Report abuse